Bibliografia UJ CM

1/4
Michael Maes, Gabriel Nowak, Javier R. Caso, Juan Carlos Leza, Cai Song, Marta Kubera, Hans Klein, Piotr Galecki, Cristiano Noto, Enrico Glaab, Rudi Balling, Michael Berk.
Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.
Molecular Neurobiology
2016 : Vol. 53, nr 5, s. 2927-2935, bibliogr. 90 poz., abstr.
p-ISSN: 0893-7648
AZ
ORG
AIF
IF: 6.190
Adres url:
Streszczenie w PubMed:
DOI:
2/4
George Anderson, Marta Kubera, Weronika Duda, Władysław Lasoń, Michael Berk, Michael Maes.
Increased IL-6 trans-signaling in depression: Focus on the tryptophan catabolite pathway, melatonin and neuroprogression.
Pharmacological Reports
2013 : Vol. 65, nr 6, s. 1647-1654, il., bibliogr. 28 poz., abstr.
p-ISSN: 1734-1140
AP
POG
AIF
IF: 2.165
Adres url:
3/4
Michael Maes, Zdenek Fisar, Miguel Medina, Giovanni Scapagnini, Gabriel Nowak, Michael Berk.
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates - Nrf2 activators and GSK-3 inhibitors.
Inflammopharmacology
2012 : Vol. 20, nr 3, s. 127-150, il., bibliogr., abstr.
p-ISSN: 0925-4692
AZ
POG
APZ
4/4
Michael Maes, Brain Leonard, Alberto Fernandez, Marta Kubera, Gabriel Nowak, Rob Veerhuis, Ann Gardner, Piaynuj Ruckoanich, Michel Geffard, Carlo Altamura, Piotr Galecki, Michael Berk.
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression : from antioxidants to kinase inhibitors.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
2011 : Vol. 35, nr 3, s. 659-663, bibliogr., abstr.
p-ISSN: 0278-5846
AZ
POG
AIF
IF: 3.247
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ